Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Night-Before Administration for Postoperative Delirium in Elderly Hip Fracture Patients
ChiCTR2200064643Phase 4Not yet recruiting
- Sponsor
- Lu'an Hospital of Anhui Medical University
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in postoperative delirium (POD) (2 arms), sponsored by Lu'an Hospital of Anhui Medical University. Primary endpoint: Incidence of postoperative delirium. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2200064643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064643.